Market Currents
Jazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward...
-
Friday, January 6, 2012, 10:03 AM ETJazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward revision for 2012 revenue. Adding to the momentum, analysts at Muzho upped their price target on shares to $62 from $52 based on the firm's rosy outlook.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
